The Chemours Company (CC) FY2026 YTD Q2 P&L / Income Statement
2026-01-01 to 2026-06-30
Revenue by Business Segment by Timing of Transfer
2026-01-01 to 2026-06-30
Swipe to see the full flow
Chart details
The Chemours Company (CC) FY2026 YTD Q2 P&L / Income Statement
Income statement for 2026-01-01 through 2026-06-30. View: Statement Business Segments by Timing Of Transfer Of Good Or Service. Revenue uses this breakdown; costs and expenses retain the consolidated categories.
- Net sales
- 2,972,000,000 US dollars
- Cost of goods sold
- 2,474,000,000 US dollars
- Gross profit
- 498,000,000 US dollars
- Total other operating expenses
- 685,000,000 US dollars
- Operating profit (calculated)
- negative 187,000,000 US dollars
- Other income (expense), net (calculated)
- 165,000,000 US dollars
- Loss before income taxes
- negative 22,000,000 US dollars
- Provision for income taxes
- 281,000,000 US dollars
- Net loss
- negative 303,000,000 US dollars
- Advanced Performance Materials - Transferred at a Point in Time
- 569,000,000 US dollars
- Other Non-Reportable Segment - Transferred at a Point in Time
- 25,000,000 US dollars
- Thermal & Specialized Solutions - Transferred at a Point in Time
- 1,158,000,000 US dollars
- Titanium Technologies - Transferred at a Point in Time
- 1,220,000,000 US dollars
- Selling, general, and administrative expense
- 616,000,000 US dollars
- Research and development expense
- 53,000,000 US dollars
- Restructuring, asset-related, and other charges
- 16,000,000 US dollars
Chart connections
- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.

Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG
Gross margin
16.8%
Gross profit / revenue
Operating margin
−6.3%
Operating profit / revenue
Product waitlist
Health Check and Teardown for your own company
A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!
